Voglibase 0.2 Md Tablet 10 is used predominantly to manage type 2 diabetes. This medicine belongs to a class of agents known as alpha-glucosidase inhibitors. In addition to its primary use, this medicine can be used along with dietary adjustments and physical exercise for better control of blood sugar levels in adults suffering from type 2 diabetes. It may also be combined with other oral antidiabetic agents to augment glycaemic control.
Uses
- Improving blood sugar control in adults with type 2 diabetes.
- Helping to slow down carbohydrate digestion and sugar absorption.
- Reducing sudden spikes in blood sugar levels after meals.
- Acting as a part of a comprehensive diabetes management plan that includes diet and exercise.
How Voglibase 0.2 Md Tablet 10 Works?Voglibase 0.2 Md Tablet 10 contains voglibose (0.2 mg) which acts on your body in the following ways:
-
Alpha-glucosidase inhibition: Voglibose inhibits a group of enzymes called alpha-glucosidase in the digestive tract. These enzymes play a vital role in transforming complex carbohydrates into simple sugars.
-
Reduction of blood sugar spikes: By slowing down the digestion of carbohydrates and hence their absorption into the bloodstream, voglibose helps manage post-meal spikes in blood sugar levels.
-
Competitive reversible inhibition: Voglibose specifically targets enzymes like sucrase, maltase, isomaltase, and glucoamylase present in the brush border area of your small intestine. By competitively and reversibly inhibiting these enzymes, it delays carbohydrate digestion even further.
Side effects
- Flatulence
- Diarrhoea
- Abdominal pain
- Constipation
- Nausea
